| Dr Nathaniel David Kofford, MD, MSPH | |
|
900 Round Valley Drive, Park City, UT 84060-7532 | |
| (435) 658-7000 | |
| (801) 990-1912 |
| Full Name | Dr Nathaniel David Kofford |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 16 Years |
| Location | 900 Round Valley Drive, Park City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407021702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 042-0011896 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park City Hospital | Park city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Anesthesia Llc | 9032018502 | 248 |
News Archive
University of California, Berkeley engineer Phillip Messersmith is happy to be learning lessons from a lowly mollusk, with the expectation that the knowledge gained will enable him and fellow physicians to prevent deaths among their youngest patients - those who haven't been born yet.
People buying their own health insurance have even more to think about this year, particularly those post-COVID-19 patients with lingering health concerns, the "long haulers," who join the club of Americans with preexisting conditions.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
Scientists from the School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments.
› Verified 7 days ago
| Entity Name | Mountain West Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558391763 PECOS PAC ID: 9032018502 Enrollment ID: O20040103000057 |
News Archive
University of California, Berkeley engineer Phillip Messersmith is happy to be learning lessons from a lowly mollusk, with the expectation that the knowledge gained will enable him and fellow physicians to prevent deaths among their youngest patients - those who haven't been born yet.
People buying their own health insurance have even more to think about this year, particularly those post-COVID-19 patients with lingering health concerns, the "long haulers," who join the club of Americans with preexisting conditions.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
Scientists from the School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathaniel David Kofford, MD, MSPH 3340 N Center St, #800, Lehi, UT 84043-7406 Ph: (801) 990-1911 | Dr Nathaniel David Kofford, MD, MSPH 900 Round Valley Drive, Park City, UT 84060-7532 Ph: (435) 658-7000 |
News Archive
University of California, Berkeley engineer Phillip Messersmith is happy to be learning lessons from a lowly mollusk, with the expectation that the knowledge gained will enable him and fellow physicians to prevent deaths among their youngest patients - those who haven't been born yet.
People buying their own health insurance have even more to think about this year, particularly those post-COVID-19 patients with lingering health concerns, the "long haulers," who join the club of Americans with preexisting conditions.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
Scientists from the School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments.
› Verified 7 days ago
Michael Buys, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8868 Saddleback Rd, Park City, UT 84098 Phone: 801-205-1040 | |
Lee Gerstein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1439 Willow Loop, Park City, UT 84098 Phone: 425-785-4141 | |
Dr. Watson Allen Bowes Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7905 Long Rifle Rd, Park City, UT 84098 Phone: 801-442-5692 | |
Courtney Mitchell Bailey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley, Park City Medical Center, Park City, UT 84060 Phone: 435-658-7000 Fax: 801-733-5618 | |
Dr. Andrew P. Talbott, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1122 Center Dr Ste D350, Park City, UT 84098 Phone: 435-714-7277 Fax: 435-214-2254 | |
Dr. Joseph Morelli, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley, Park City Medical Center, Park City, UT 84060 Phone: 435-658-7000 |